Baolingbao Biology Co.,Ltd. (SHE:002286)
China
· Delayed Price · Currency is CNY 10.63
+0.07 (0.66%)
Mar 9, 2026, 3:04 PM CST
Baolingbao Biology Revenue
Baolingbao Biology had revenue of 727.13M CNY in the quarter ending September 30, 2025, with 12.23% growth. This brings the company's revenue in the last twelve months to 2.69B, up 12.64% year-over-year. In the year 2024, Baolingbao Biology had annual revenue of 2.40B, down -4.84%.
Revenue (ttm)
2.69B
Revenue Growth
+12.64%
P/S Ratio
1.50
Revenue / Employee
1.93M
Employees
1,395
Market Cap
4.05B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 2.40B | -122.16M | -4.84% |
| Dec 31, 2023 | 2.52B | -188.83M | -6.96% |
| Jan 1, 2023 | 2.71B | -52.23M | -1.89% |
| Jan 1, 2022 | 2.76B | 710.40M | 34.58% |
| Dec 31, 2020 | 2.05B | 249.41M | 13.82% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Zhejiang Wecome Pharmaceutical Company | 131.67M |
| Qingdao Vland Biotech INC. | 1.39B |
| Zhejiang Shouxiangu Pharmaceutical | 642.66M |
| Boji Medical Technology | 770.19M |
| Guanhao Biotech | 392.83M |
| Hinova Pharmaceuticals | 20.67M |
| Shenzhen Bioeasy Biotechnology | 251.83M |
| Shanghai Shen Lian Biomedical | 288.27M |